An intercostal nerve block is a targeted interventional procedure that delivers local anesthetic and corticosteroid directly to one or more intercostal nerves as they course along the inferior border of each rib within the intercostal neurovascular bundle. The intercostal nerves are the anterior rami of the T1 through T11 thoracic spinal nerves, and they provide sensory innervation to the skin, muscles, and parietal pleura of the chest wall and upper abdominal wall. When these nerves become inflamed, compressed, or irritated — whether from viral infection (herpes zoster), trauma (rib fracture), surgical manipulation (thoracotomy), or idiopathic causes — the resulting neuropathic pain can be severe, debilitating, and resistant to standard pharmacologic therapies.
The clinical applications of intercostal nerve blocks span both acute and chronic pain settings. In the acute setting, intercostal blocks are invaluable for managing pain from rib fractures — including the unstable, osteoporotic fragility fractures common in the elderly population — as they provide profound regional analgesia without the respiratory depressant effects of systemic opioids, which is particularly critical in patients with compromised pulmonary function or underlying chronic lung disease. In the chronic pain setting, intercostal nerve blocks are a first-line interventional treatment for post-herpetic neuralgia (PHN) involving a thoracic dermatome, a notoriously difficult-to-treat neuropathic pain condition that can persist for months to years after the initial herpes zoster rash has resolved.
At Interventional Pain Consultants, intercostal nerve blocks are performed under ultrasound or fluoroscopic guidance by board-certified, fellowship-trained interventional pain specialists. The thin, highly vascular anatomy of the intercostal space demands precise image guidance to ensure that the injectate is deposited accurately on the nerve while avoiding intravascular injection (which could result in local anesthetic systemic toxicity), pleural puncture (which could cause pneumothorax), or injury to the intercostal vessels that travel in close proximity to the nerve within the costal groove.
The patient is positioned prone, lateral decubitus, or sitting upright depending on the location of the target rib levels and patient comfort. Under ultrasound or fluoroscopic guidance, the appropriate rib is identified by counting down from the first rib (which articulates with the T1 vertebral body) or up from the 12th rib. The skin entry point is marked at the posterior angle of the rib, approximately 6-8 cm lateral to the spinous process, where the intercostal nerve occupies the intercostal groove — a sulcus on the inferior inner surface of the rib — between the internal intercostal muscle (deep) and the innermost intercostal muscle (superficial).
After sterile preparation, a 25- or 27-gauge, 1.5-inch needle is advanced until the tip makes contact with the periosteum of the lower border of the selected rib. The needle is then walked off the inferior margin of the rib and advanced approximately 2-3 mm deeper, where it enters the intercostal space adjacent to the neurovascular bundle. After negative aspiration, 2-3 mL of injectate — typically 0.25-0.5% bupivacaine combined with 20-40 mg of methylprednisolone acetate — is deposited at each level. For patients requiring multiple-level blocks (e.g., three or more adjacent levels), the cumulative local anesthetic dose must be carefully calculated to avoid exceeding the maximum safe dose.
Each intercostal nerve block is a quick procedure, requiring approximately 5-10 minutes per level. Patients may feel a brief stinging sensation from the local anesthetic skin infiltration, followed by pressure during needle advancement to the rib. When the anesthetic is injected, patients typically experience immediate numbness and a sensation of warmth in the chest wall distribution of the blocked nerve — a reassuring sign that the block is technically successful.
Following the procedure, patients are monitored for 20-30 minutes. A post-procedure breath sound assessment and, if any concern arises, an ultrasound evaluation of the pleura is performed to rule out pneumothorax — the most clinically significant potential complication, though its incidence is very low (less than 1%) in experienced hands with image guidance. Patients and their accompanying caregivers are given specific discharge instructions regarding the signs and symptoms of delayed pneumothorax (chest pain, shortness of breath, oxygen desaturation) with clear guidance to seek immediate medical attention should these develop.
The immediate analgesic effect of the local anesthetic provides several hours of profound pain relief, during which patients can comfortably perform deep breathing exercises, coughing, and incentive spirometry — activities that are critical for preventing atelectasis and pneumonia in patients with rib fractures or post-thoracotomy pain. The therapeutic benefit of the corticosteroid component becomes apparent within 2-5 days and reaches peak effect at approximately 7-14 days post-injection.
Patients should avoid heavy lifting, strenuous upper body exercise, and submersion of the injection site for 24-48 hours. If multiple levels were injected, patients may notice a patchy area of chest wall numbness corresponding to the blocked dermatomes, which resolves as the local anesthetic is metabolized over 6-12 hours. A series of 2-3 blocks spaced 3-6 weeks apart may be recommended for patients with post-herpetic neuralgia or chronic intercostal neuralgia.
Intercostal nerve blocks are most effective in patients whose chest wall pain has a demonstrable neuropathic component — identified by the presence of burning, shooting, or electric-shock-like pain in a dermatomal distribution, with associated allodynia, hyperalgesia, or sensory changes. The presence of a rash or scarring in a thoracic dermatomal distribution (in the case of post-herpetic neuralgia) or a history of rib trauma or thoracic surgery provides important diagnostic context.
Contraindications include coagulopathy or therapeutic anticoagulation that cannot be safely interrupted, active infection at the injection site, known allergy to local anesthetics or corticosteroids, preexisting pneumothorax or severe bullous lung disease, and patient refusal. At Interventional Pain Consultants, we adhere to the highest standards of procedural safety, employing real-time image guidance with contrast confirmation when indicated, meticulous sterile technique, and comprehensive patient education to ensure optimal outcomes for every patient undergoing intercostal nerve block therapy.
Reducing Pain. Improving Function. Enhancing Quality of Life.
We specialize in advanced pain management solutions, offering minimally invasive treatments to help patients live pain-free and improve their quality of life.